NCT06840964View on ClinicalTrials.gov

Effect of Omega 3 in Hypertensive Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

June 3, 2024

Study Completion Date

August 30, 2024

Conditions
HypertensionDyslipidemia
Interventions
DIETARY_SUPPLEMENT

omega 3 ethyl esters at 90%

2 grams/day of omega 3 capsules will be administered orally, for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Mygliol 812

Trial Locations (1)

1642

Santa Maria de la Salud, San Isidro

All Listed Sponsors
collaborator

Gador S.A.

INDUSTRY

lead

Santa Maria de la Salud, Argentina

OTHER

NCT06840964 - Effect of Omega 3 in Hypertensive Patients | Biotech Hunter | Biotech Hunter